Jeffrey Miner, based in San Diego, California, United States, is currently a Chief Scientific Officer at Organovo Holdings, bringing experience from previous roles at Verdin Biosciences, Viscient Bio, Pharmadiscovery Consulting and Astrazeneca. Jeffrey Miner holds a 1989 - 1993 University of California, San Francisco. With a robust skill set that includes Drug Discovery, Clinical Development, Assay Development, Biotechnology, Oncology and more, Jeffrey Miner contributes valuable insights to the industry. Jeffrey Miner has 2 emails and 2 mobile phone numbers on RocketReach.